Ocular Therapeutix™ to Host Investor Day on Sept 30, 2025
Ocular Therapeutix will host an Investor Day in New York City on September 30, 2025, centered on Axpaxli, its...
Nurexone Secures U.S. Patent for Exosome Manufacturing
Nurexone Biologic has received a notice of allowance from the U.S. Patent and Trademark Office for a patent covering...
Immix BioPharma Secures Strategic Investment from Goose Capital
Immix Biopharma has secured a strategic investment from Goose Capital and Dr. Nancy T. Chang, the former Tanox CEO...
Cosmos Health Signs Oman Deal in $7B Nutraceuticals Market
Cosmos Health’s Sky Pharm has signed a distribution agreement with Scientific Pharmacy, the retail and wholesale arm of Planet...
CBSC Launches Sizable Revenue Program with Noventis Medical
Cardiac Biotech Solutions has booked an initial international order for 2,500 MyCardia AT cardiac event monitoring devices from Noventis...
Foxo Technologies Announces Acquisition of Vector Biosource
FOXO Technologies has signed a stock purchase agreement to acquire Vector BioSource, an information, data, and biospecimen sourcing provider...
Scancell Reports 2025 Financial Results & Business Update
Scancell released full-year results alongside a business update anchored by positive phase 2 melanoma data and a more straightforward...
Bioversys Reports H1 2025 Financials & Corporate Highlights
BioVersys has entered the late-stage development of antimicrobial resistance. Following a successful end-of-Phase-2 meeting with the FDA, the company...
Bioversys Reports Key Financials and Highlights for H1 2025
BioVersys reported a busy first half: a successful end-of-Phase two meeting with the FDA for BV100 in ventilator-associated bacterial...
Scancell Reports Business Update and Financial Results
Scancell has reported robust Phase 2 data for its next-generation DNA vaccine iSCIB1+ in advanced melanoma, confirmed plans to...